A PYMNTS Company

Russia: Competition watchdog clears pharmaceutical merger

By  |  December 7, 2014

Russia’s antitrust authority has granted approval for Pharmacy Chain 36.6 to acquire the Russian operations of Finnish peer Oriola-KD, according to reports.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Pharmacy Chain 36.6 is set to purchase the retail and wholesale drug chain for about $123 million after Russia’s Federal Antimonopoly Service found the deal would not harm competition. Experts say the merger could benefit the Russian market, which as taken hits in recent months due to Western sanctions for its political action in Ukraine.

    Oriola-KD was hit with an impairment charge last June, say reports, for weaker growth prospects within Russia.

    Full content: The Moscow Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.